Home Cart Sign in  
Chemical Structure| 872365-14-5 Chemical Structure| 872365-14-5

Structure of Fevipiprant
CAS No.: 872365-14-5

Chemical Structure| 872365-14-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fevipiprant is a selective, potent, reversible competitive CRTh2 antagonist with an in vitro dissociation constant KD value of 1.1nM at the CRTh2 receptor and an IC50 value of 0.44 nM for inhibition of PGD2-induced eosinophil shape change in human whole blood.

Synonyms: NVP-QAW039; QAW039; NVP-QAW-039 QAW-039

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fevipiprant

CAS No. :872365-14-5
Formula : C19H17F3N2O4S
M.W : 426.41
SMILES Code : O=C(O)CC1=C(C)N(CC2=CC=C(S(=O)(C)=O)C=C2C(F)(F)F)C3=NC=CC=C31
Synonyms :
NVP-QAW039; QAW039; NVP-QAW-039 QAW-039
MDL No. :MFCD28963975
InChI Key :GFPPXZDRVCSVNR-UHFFFAOYSA-N
Pubchem ID :23582412

Safety of Fevipiprant

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03989635 Asthma|Asthma, Bronchial|Bronc... More >>hial Asthma|Eosinophilia|Physiological Effects of Drugs Less << PHASE2 WITHDRAWN 2021-06-14 -
NCT03650400 Asthma PHASE2 TERMINATED 2020-01-22 Novartis Investigative Site, M... More >>inneapolis, Minnesota, 55402, United States|Novartis Investigative Site, Columbia, Missouri, 65203, United States|Novartis Investigative Site, Tulsa, Oklahoma, 74136, United States|Novartis Investigative Site, Boerne, Texas, 78006, United States|Novartis Investigative Site, El Paso, Texas, 79903, United States|Novartis Investigative Site, San Antonio, Texas, 78229, United States Less <<
NCT03048448 Hepatic Impairment PHASE1 COMPLETED 2019-04-22 Novartis Investigative Site, A... More >>naheim, California, 92801, United States|Novartis Investigative Site, Orlando, Florida, 32809, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.23mL

11.73mL

2.35mL

1.17mL

23.45mL

4.69mL

2.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories